(1)
Patient-Level, Visit-by-Visit Data Highlight the Extent of Skin and Itch Improvement in Atopic Dermatitis With Lebrikizumab. J of Skin 2023, 7 (6), s275. https://doi.org/10.25251/skin.7.supp.275.